INCB018424 is a potent and selective inhibitor of Janus-associated kinase (JAK) 1 and 2, with IC50 to be 2.7, 4.5 and 332 nM for JAK1, JAK2 and JAK3 respectively;
More Information Supplier PageINCB018424 is a potent and selective inhibitor of Janus-associated kinase (JAK) 1 and 2, with IC50 to be 2.7, 4.5 and 332 nM for JAK1, JAK2 and JAK3 respectively;
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
More Information Supplier PageTubastatin A HCl is a potent HDAC inhibitor that demonstrates over more selectivity than all other HDAC isoforms (IC50s >16 uM), excluding HDAC8 (IC50 = 0.9 M).
More Information Supplier PageTubastatin A HCl is a potent HDAC inhibitor that demonstrates over more selectivity than all other HDAC isoforms (IC50s >16 uM), excluding HDAC8 (IC50 = 0.9 M).
More Information Supplier PageTAK-700 (Orteronel) is an oral, non-steroidal androgen synthesis inhibitor that selectively inhibits the 17,20 lyase enzyme.
More Information Supplier PageTAK-700 (Orteronel) is an oral, non-steroidal androgen synthesis inhibitor that selectively inhibits the 17,20 lyase enzyme.
More Information Supplier Page
